Pharmaceutical manufacturers constantly seek high-purity ingredients to ensure patient safety. Edoxaban tosylate raw material serves as the critical active component in modern anticoagulant medications. This Direct Oral Anticoagulant (DOAC) specifically inhibits Factor Xa, a key enzyme in the blood coagulation pathway. Sourcing high-quality edoxaban tosylate raw material requires a deep understanding of its chemical properties, regulatory requirements, and the global supply chain landscape. This guide provides the technical and market insights necessary for effective procurement and formulation.
What is Edoxaban Tosylate Raw Material (Monohydrate)?
Edoxaban tosylate raw material is the tosylate salt form of Edoxaban. Chemists designate it with the unique identifier CAS No. 480449-71-6. The full chemical name refers to N-(5-Chloropyridin-2-yl)-N’-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)cyclohexyl]oxamide mono-p-toluenesulfonate monohydrate.
Chemical Structure and Properties
The molecule exists as a white to pale yellowish-white crystalline powder. The tosylate salt formation significantly improves the compound’s solubility compared to the free base. This enhancement is important for bioavailability. The molecular weight of edoxaban tosylate monohydrate stands at approximately 738.27 g/mol.
Solubility is pH-dependent. It shows slight solubility in water and higher solubility in acidic media. Stability studies indicate that the material remains stable under normal storage conditions, provided manufacturers control humidity levels strictly.
Applications in Pharmaceutical Formulations
Formulators use edoxaban tosylate pharmaceutical raw materials primarily to produce oral tablets. Physicians prescribe these medications to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). Additionally, it treats deep vein thrombosis (DVT) and pulmonary embolism (PE). The high specificity of Edoxaban for Factor Xa makes it a preferred choice over traditional warfarin therapy.
Top Edoxaban Tosylate API Suppliers and Selection Criteria
Identifying reliable edoxaban tosylate api suppliers safeguards your production line against disruptions. The market contains numerous vendors, but quality levels vary significantly.
Leading Global Suppliers and Certifications
Top-tier suppliers hold specific certifications. You must look for edoxaban tosylate manufacturers who possess valid GMP (Good Manufacturing Practice) certificates. Furthermore, a valid DMF (Drug Master File) submission to regulatory bodies like the US FDA or EMA is non-negotiable. Suppliers with a CEP (Certificate of Suitability) offer streamlined compliance for European markets.
Factors to Consider When Sourcing API
Procurement managers must evaluate the impurity profile of the edoxaban tosylate bulk supply. High purity (>99.5%) is the standard. Specifically, you should check for the levels of genotoxic impurities. Edoxaban tosylate price is another major factor. You should prioritize suppliers who offer a balance of cost-efficiency and regulatory compliance.
Role of Suppliers in Supply Chain Integrity
Dependable suppliers ensure consistent lead times. They provide necessary technical documentation, such as the Certificate of Analysis (CoA) and Material Safety Data Sheets (MSDS). In fact, a robust supplier relationship mitigates risks associated with regulatory audits.
Critical Edoxaban Tosylate Intermediates in Synthesis
The quality of the final API depends directly on the quality of its precursors. Edoxaban tosylate intermediates are the building blocks of the final molecule.
Description of Key Intermediates
The synthesis pathway involves several complex steps. One critical intermediate is the tert-butyl carbamate derivative. Another key building block is the thiazolo-pyridine ring system. Manufacturers must control the stereochemistry of the cyclohexane ring rigorously. If the chirality is incorrect at the intermediate stage, the final edoxaban tosylate raw material will fail optical rotation tests.
Quality Control in Intermediate Production
Impurity tracking starts here. Unreacted reagents from the intermediate stage can carry over to the final API. Consequently, manufacturers must implement strict Quality Control (QC) protocols for every batch of intermediates.
Challenges in Procurement
Sourcing these specialized chemicals presents challenges. Environmental regulations in production hubs like China often disrupt the supply of raw chemical precursors. Therefore, you should qualify multiple sources for key intermediates to secure your supply chain.
Edoxaban Tosylate Manufacturers: Global Market Landscape
The global landscape for edoxaban tosylate manufacturers is competitive and dynamic. Production hubs are concentrated in specific regions.
Overview of Major Manufacturers
India and China dominate the manufacturing sector for this API. Indian manufacturers often focus on regulated markets like the USA and EU. They invest heavily in compliance and documentation. Conversely, some Chinese manufacturers focus on high-volume edoxaban tosylate bulk supply for emerging markets. European manufacturers also exist. They typically offer premium products with extensive regulatory backing.
Manufacturing Standards
All reputable manufacturers adhere to ICH Q7 guidelines for API manufacturing. These standards dictate facility maintenance, equipment cleaning, and personnel training. Compliance ensures that the edoxaban tosylate raw material is free from cross-contamination.
Innovations in Production Techniques
Leading manufacturers now adopt green chemistry principles. They replace hazardous solvents with eco-friendly alternatives. Additionally, flow chemistry techniques optimize reaction yields. These innovations reduce waste and lower the overall edoxaban tosylate production process costs.
Step-by-Step Edoxaban Tosylate Synthesis Process
Understanding the edoxaban tosylate synthesis process helps in evaluating supplier capabilities. The route involves precise organic chemistry.
Chemical Synthesis Route
The synthesis generally begins with the formation of the core diamine structure.
- Coupling: The diamine reacts with an activated oxalate derivative.
- Cyclization: The thiazole ring forms through a condensation reaction.
- Salt Formation: The final step involves reacting the Edoxaban free base with p-toluenesulfonic acid. This step creates the edoxaban tosylate monohydrate.
Optimization of Reaction Conditions
Process engineers optimize temperature and pressure to maximize yield. Solvent selection is also critical. The right solvent system ensures the correct crystal polymorph forms during crystallization.
In-Process Controls (IPC)
Operators perform In-Process Controls at every stage. They check the reaction completion using HPLC (High-Performance Liquid Chromatography). If the reaction is incomplete, they adjust the conditions immediately. This proactive monitoring prevents the waste of expensive edoxaban tosylate raw material precursors.
Frequently Asked Questions (FAQ)
What is the shelf life of Edoxaban Tosylate raw material?
Typically, the shelf life is 24 to 36 months. This depends on the packaging and storage conditions. You must store it in air-tight containers protected from light and moisture to maintain stability.
How does Edoxaban Tosylate differ from other Factor Xa inhibitors?
Edoxaban has a unique metabolic profile. It relies less on the CYP3A4 pathway compared to rivaroxaban or apixaban. This feature reduces drug-drug interactions. Additionally, its once-daily dosing regimen improves patient adherence.
What are the storage requirements for Edoxaban API?
You should store the material at controlled room temperature (15°C to 30°C). The warehouse must be dry. Exposure to high humidity can cause the monohydrate form to absorb excess moisture or degrade.
